News

February 21, 2019February 21, 2019

Higher Levels of 2 Autoantibodies Could Help Diagnose CTEPH and PAH, Study Suggests

CTEPH News, News, PAH News

Patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) have higher serum levels of antibodies against the EDX2 and PHAX proteins, according to research which suggests ... Read more

February 21, 2019February 21, 2019

Vienna to Host RARE2019 Meeting on Rare Diseases

News

About 100 scientists, researchers, pharmaceutical executives, and others will converge on Austria’s capital city early next month for the 2nd International Congress on Advanced Treatments in Rare Diseases. The ... Read more

February 20, 2019February 20, 2019

Balloon Pulmonary Angioplasty Can Shorten CTEPH Patients’ Hospital Stays, Study Reports

CTEPH News, News

Greater experience in balloon pulmonary angioplasty (BPA) enables shorter hospital stays for patients with chronic thromboembolic pulmonary hypertension (CTEPH), reduces use of intensive care, and lowers medical costs while maintaining the ... Read more

February 18, 2019February 22, 2019

Approved Lung Cancer Therapy Dacomitinib Shows Promise in Treating PAH, Animal Study Finds

News, PAH News

Dacomitinib, a medicine recently approved by the U.S. Food and Drug Administration for the treatment of certain forms of lung cancer, showed promising therapeutic effects in two animal models ... Read more

February 15, 2019February 22, 2019

Pulmonary Artery Denervation Can Improve CpcPH Patients’ Outcome, Trial Shows

News

Invasive pulmonary artery denervation is safe and can improve the outcome of patients with combined pre- and post-capillary pulmonary hypertension associated with left heart failure, compared with standard of ... Read more

February 14, 2019February 20, 2019

Ventavis Improves Right Ventricle Function in Certain PAH Patients, Study Shows

News, PAH News

Acute treatment with Ventavis (iloprost) improves the heart’s right ventricular (RV) function in patients with idiopathic pulmonary arterial hypertension (IPAH) and PAH associated with connective tissue disease (CTD-PAH), according ... Read more

February 13, 2019February 18, 2019

CHEST Releases Updated Guidelines for PAH Treatment

News

An updated guideline with new recommendations for the treatment of patients with pulmonary arterial hypertension (PAH) was released by the American College of Chest Physicians (CHEST). The free guide, titled “Therapy ... Read more

February 12, 2019February 12, 2019

Patients, Family and Friends to Take Part in Variety of Rare Disease Day Events Worldwide

News

Scores of events are afoot worldwide to mark Feb. 28, Rare Disease Day 2019. The activities aim to raise awareness about rare diseases and the millions of people — estimates run ... Read more

February 11, 2019February 11, 2019

Wireless Monitoring May Help Transition of Therapy in PAH, Study Suggests

News

An implantable wireless system may help guide the transition from medication administered intravenously — Remodulin (treprostinil) — to one taken orally — Uptravi (selexipag) — in the treatment of pulmonary arterial hypertension (PAH), according ... Read more

February 8, 2019February 14, 2019

Generic Version of Adcirca to be Launched in US Under Brand Name ALYQ for PAH

News, PAH News

Teva Pharmaceutical Industries announced the launch of a generic version of Adcirca (tadalafil) under the brand name ALYQ for the treatment of pulmonary arterial hypertension (PAH) in the United States. PAH ... Read more

Pin It on Pinterest